• Baxter International (Deerfield, Illinois) has named two senior executives to key leadership roles. Susan Lichtenstein has been named corporate vice president, general counsel and corporate secretary. And Peter Arduini has been named corporate vice president and president of the company's Medication Delivery business, replacing David Drohan, who will retire in November. Both executives will assume their new responsibilities with Baxter in mid-April. Most recently, Lichtenstein was a partner with the law firm of McDermott Will & Emery. Arduni most recently was global general manager of the CT scan and functional imaging business of GE Healthcare. Baxter, through its subsidiaries, applies its healthcare expertise in the areas of medical devices, pharmaceuticals and biotechnology.

• Gene Saragnese has been promoted to vice president and general manager of GE Healthcare's (Waukesha, Wisconsin) Global Functional and Computed Tomography (FCT) business. Saragnese replaces Peter Arduini, who will leave the company in early April. Saragnese, a career veteran of GE and a GE officer, formely led GE Healthcare's Global Technology organization. GE's FCT business develops CT systems, as well as positron emission tomography/computed tomography, nuclear medicine and radiopharmacy systems.

• Monitorforhire.com (Philadelphia), which describes itself as "the life science industry's largest web-based resource for hiring qualified independent clinical trial monitors," has added Charlie Nucera as an account executive and Elizabeth Klaes as manager of clinical operations for the company's San Diego office. Previously, Nucera worked for a clinical staffing firm, and before that, GlaxoSmithKline and Johnson & Johnson Pharmaceutical Research & Development. Klaes previously worked with a global contract research organization, where she was responsible for managing a global project team.

• Stephen Tang will serve as the first vice president for life science business development at Olympus America (Melville, New York). Tang will direct the company's expanding role in the life science research sector, focusing on Olympus' growing presence in the genome, proteome and cellome arena. Tang most recently was president, CEO and a director of Millennium Cell.

• Recom Managed Systems (Los Angeles), focused on the monitoring and detection of disease through continuous biomedical signal monitoring, appointed two former Johnson & Johnson executives, Rodney Hildebrandt and Pamela Bunes. At the same time, Marvin Fink and Robert Koblin have retired as directors, although Fink remains the CEO of the company – in a somewhat reduced role – to assure operational and transitional integrity as the company now moves to commercialization of its products. Hildebrandt and Bunes replace Fink and Koblin in their roles as members of the board. Rodney Hildebrandt has been named chief operating officer of Recom, and has accepted a five-year tenure on the company's board. Hildebrandt has more than 30 years' experience at Johnson & Johnson where he performed numerous high-level executive roles.

• Acting CEO Rick Spurr has been appointed CEO of Zix (Dallas), replacing John Ryan. Spurr joined Zix in January 2004 as president and chief operating officer, and will retain those duties. Zix is a global provider of secure e-messaging, e-prescribing and e-transaction applications and services.